These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19924796)
1. We need better randomized comparison trials of prostate cancer. Lee WR Cancer; 2010 Jan; 116(2):270-2. PubMed ID: 19924796 [No Abstract] [Full Text] [Related]
2. Design and analysis of prostate cancer trials. Sylvester R Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926 [TBL] [Abstract][Full Text] [Related]
3. Understanding participation in a trial comparing cryotherapy and radiation treatment. Eng M; Taylor L; Verhoef M; Ernst S; Donnelly B Can J Urol; 2005 Apr; 12(2):2607-13. PubMed ID: 15877944 [TBL] [Abstract][Full Text] [Related]
8. Cryotherapy for prostate cancer: what we know, what we need to know. Theodorescu D J Urol; 2008 Aug; 180(2):437-8. PubMed ID: 18550127 [No Abstract] [Full Text] [Related]
10. Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer. Bolla M; Descotes JL; Artignan X; Fourneret P BJU Int; 2007 Jul; 100 Suppl 2():44-7. PubMed ID: 17594359 [No Abstract] [Full Text] [Related]
11. Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial. PR06 Collaborators BJU Int; 2004 Dec; 94(9):1400-1. PubMed ID: 15610132 [No Abstract] [Full Text] [Related]
12. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer]. Bolla M; Fourneret P; Descotes JL Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656 [TBL] [Abstract][Full Text] [Related]
13. Screening for prostate cancer. Early screening is important despite lack of data from trials. Catalona WJ BMJ; 1997 Jul; 315(7101):187. PubMed ID: 9251561 [No Abstract] [Full Text] [Related]
14. Prospective validation of active surveillance in prostate cancer: the PRIAS study. van den Bergh RC; Roemeling S; Roobol MJ; Roobol W; Schröder FH; Bangma CH Eur Urol; 2007 Dec; 52(6):1560-3. PubMed ID: 17532115 [No Abstract] [Full Text] [Related]
15. [Established and new urological therapeutic options in the management of prostate carcinoma]. Michel MS; Trojan L; Knoll T; Bross S; Alken P Radiologe; 2003 Jun; 43(6):441-7. PubMed ID: 12827258 [TBL] [Abstract][Full Text] [Related]
17. Side-effects of treatments for locally advanced prostate cancer. Gardiner RF; Nicol DL; Green HJ; Pakenham KI BJU Int; 2006 Jul; 98(1):229-30. PubMed ID: 16831173 [No Abstract] [Full Text] [Related]
18. Radiation in high-risk prostate cancer: how much is enough? Payne H BJU Int; 2008 Sep; 102(6):663-5. PubMed ID: 18476968 [No Abstract] [Full Text] [Related]
19. Androgen suppression therapy and prostate cancer: balancing the harms and the benefits. Oefelein MG Cancer; 2008 Dec; 113(12):3275-8. PubMed ID: 18988289 [No Abstract] [Full Text] [Related]
20. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]